The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors
Eun‐Jeong Yu(National Institutes of Health), Daphne W. Bell(Harvard University)
Cited by 1
Related Papers
Genetic and functional analysis of <i>CHEK2</i> (<i>CHK2</i>) variants in multiethnic cohorts
|International Journal of Cancer|2007|90